Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

App and bottle combo aims to flush away kidney stones

NCT ID NCT06269783

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a system called sipIT that uses a smart water bottle and phone app to track fluid intake and send reminders. The goal was to see if it helps kidney stone patients form a habit of drinking more fluids. 172 adults with a recent kidney stone diagnosis used the system for 3 months. The study focused on understanding how behavior change works, not on directly treating stones.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sipIT fluid tracking system with reminders
What this could lead to
If successful, this could point toward a simple, app-based way to help kidney stone patients drink more fluids and reduce stone risk.
What could go wrong
This is a small, completed study focused on understanding behavior change, not on proving that the intervention prevents stones. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

172 people

The number who actually took part.

Started

Jan 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Previous diagnosis of symptomatic kidney stone in the past 5 years, * Age 18 or older, * Own an iOS or Android smart phone, * Proficient in English, * Capable of providing informed consent, * Willing to use the water bottle and companion app \& receive text message reminders for 3 months, * Live in continental US. Exclusion Criteria: * Pregnant or planning to become pregnant during the next 6 months, * Concurrently participating in other study involving fluid intake or diet, * Plan to have surgery in the next 6 months, * Co-morbidities that preclude high fluid intake (congestive heart failure, end-stage renal disease, chronic hyponatremia), or * Active medical treatments that would impair protocol compliance.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Kidney stone are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Pennsylvania State University

    University Park, Pennsylvania, 16802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.